Cargando…
Strategies to Reduce Errors Associated with 2-Component Vaccines
The high incidence of error reports received by the US Food and Drug Administration (FDA) involving 2-component vaccines led to collaboration between the United States Pharmacopeia (USP) and the Institute for Safe Medication Practices (ISMP). This collaborating group sought to further understand err...
Autores principales: | Samad, Farzana, Burton, Samantha J., Kwan, Diana, Porter, Noah, Smetzer, Judy, Cohen, Michael R., Tuttle, Jeanne, Baker, Danial, Doherty, Dennis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846520/ https://www.ncbi.nlm.nih.gov/pubmed/33151497 http://dx.doi.org/10.1007/s40290-020-00362-9 |
Ejemplares similares
-
An Error
Publicado: (1884) -
Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
por: Atzor, Sabine, et al.
Publicado: (2013) -
Novel Strategies for the Treatment of COVID-19
por: McCarthy, Matthew W.
Publicado: (2022) -
Embedding Patient-Centricity by Collaborating with Patients to Transform the Rare Disease Ecosystem
por: Sharma, Rohita, et al.
Publicado: (2023) -
Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy
por: Burton, G.J., et al.
Publicado: (2009)